Relief From Neuropathic Pain
D’OXYVA® (deoxyhemoglobin vasodilator) is a novel, clinically validated blood flow and nerve stimulant for people suffering from Neuropathy. In multiple clinical trials, D’OXYVA has validated leading independent research results and demonstrated above-average results in improving a host of physiological functions at the same time.
Subjects suffering from high blood sugar have reported neuropathy pain relief minutes after D’OXYVA was administered and long-term blood sugar level improvements in just a few weeks.
In human clinical trials the rapid and gentle transdermal (over-the-skin) delivery of the D’OXYVA device has improved the blood microcirculation or perfusion index (PI) by 33%* on average in all participants. (Measured lasting results at 5–60 minutes and up to 4 hours after single 5–minute D’OXYVA delivery on skin surface, no reduction in PI levels.)
D’OXYVA® pairs with the TeslaMax® System for increased clinical efficacy treating patients with Neuropathy. Our network of doctors report patients can finally get lasting relief from their symptoms without the use of drugs or surgery. The proof is not only in their patients, but in the clinical testing done by the FDA.
The patented electrical stim technology of the TeslaMax® system helps to increase perfusion, oxygenation and blood flow to the treatment area which boosts lymphatic output, works the capillaries to help regenerate nerve endings and tissue regrowth to accelerate wound healing. The TeslaMax® is paired well with the micro-circulation therapy of D’OXYVA® for Neuropathy treatment.
D’OXYVA® has demonstrated triggering protective physiological functions in the body: vasodilation and vasoconstrictions in the vessels, catalyzing vessel structure growth (angiogenesis), autoregulation of local blood supply in tissues and organs, neuroreceptor signaling in the brain and balancing blood pH, among other critical functions, which has demonstrated triggering protective physiological functions in the body: vasodilation and vasoconstrictions in the vessels, catalyzing vessel structure growth (angiogenesis), autoregulation of local blood supply in tissues and organs, neuroreceptor signaling in the brain and balancing blood pH, among other critical functions.
Loving my D’OXYVA! I just had a major surgery and was introduced to D’OXYVA, they said it will make my healing faster so I can go back to work right away. I feel a whole lot healthier ever since I tried the therapy. The doctor said normally my wound will heal in 6 months, but in only almost 4 months my wounds are closed and I’m back on my feet with almost no pain! Been having the therapy once a day for the past 3 months!
I needed more information about D’OXYVA and their customer service agent immediately answered my questions and was very informative. I signed up for their 30day trial and so far my after surgery pain is being relieved and the wound is healing faster. I’m almost done with my trial and will surely continue maybe with their subscription plan!
I suffered a major injury to my ankle requiring surgery. After getting the recommended dosage from Jennifer I was able to incorporate my treatments in line with what my doctor had me doing. I honestly believe that the use of D’OXYVA significantly decreased my recovery time and allowed me to return to work 3 weeks sooner than my doctor anticipated. I would recommend this product to anyone dad wants to speed up recovery from injuries or surgery.
Take two 16g cartridges each day, in the morning and at night for the first month. Measure your results of blood flow and pain then adjust dosing accordingly to one per day in the second month.
For maintenance, take two or three 16g cartridges each week for as long as you can to avoid the reoccurence of pain. Engage in light exercise such as swimming, stretching, walking, meditation, yoga and the like to improve results.
Pair customized treatment plans pair well with other equipment and established protocols: Contact us now >>
*Six years of excellent user feedback and over two dozen clinical studies demonstrated outsized results at clinics and at home with zero adverse events. For example, D’OXYVA® (deoxyhemoglobin vasodilator) has been recording significant results also as a varicose vein treatment while delivering major clinical outcomes for well over 90% of users. Average results rounded for display, based on number of enrolled subjects in each clinical study with D’OXYVA and user feedback.